Skip to main content

Mining the transcriptome: using big data and AI to drive drug discovery the smart way

By 2022년 01월 18일1월 21st, 2022No Comments

KaiPharm’s KMAP platform combines drug-induced transcriptome profiles and artificial intelligence to accelerate drug development and drug repositioning.

View the full article in Nature Biopharma Dealmakers

Leave a Reply

error: Content is protected !!